GAL and neoplasm: Gal modification enables nanoparticles to target the salivary acid soup protein receptor on HepG2 to achieve a liver-targeting effect, while PDA modified on the MSN surface has the effect of pH response release, which can release Asp in the acidic microenvironment of a tumor.